Avalo Therapeutics (AVTX) Gains from Investment Securities (2018 - 2026)
Avalo Therapeutics' (AVTX) quarterly Gains from Investment Securities came in at $135.6 million in Q4 2024, up 476.32% on a QoQ basis from -$36.0 million in Q3 2024.
Powered by 
Analysis
Avalo Therapeutics (AVTX) Gains from Investment Securities (2018 - 2026) Analysis & Trends
Avalo Therapeutics (AVTX) has 4 years of Gains from Investment Securities data on file, last reported at $135.6 million in Q4 2024.
- Quarterly Gains from Investment Securities changed N/A year-over-year to $135.6 million in Q4 2024, while the trailing twelve-month figure through Dec 2025 was $135.6 million (up 103.02% YoY) and the FY2024 annual result came in at -$12.5 million, changed N/A from the prior year.
- Gains from Investment Securities improved to $135.6 million in Q4 2024, from -$36.0 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $1.7 billion in Q4 2022 to a low of -$112.0 million in Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Avalo Therapeutics | 843.26 Mn | 843.26 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.57 Mn |
| Dec 31, 2024 | 26.46 Mn |
| Sep 30, 2024 | -36.03 Mn |
| Jun 30, 2024 | -112.05 Mn |
| Mar 31, 2024 | 79.28 Mn |
| Dec 31, 2022 | 1.70 Bn |
| Dec 31, 2019 | -1.00 |
| Sep 30, 2019 | -197,220.00 |
| Jun 30, 2019 | -992,350.00 |
| Mar 31, 2019 | 180,402.00 |
| Dec 31, 2018 | -302,484.00 |
| Sep 30, 2018 | 84,842.00 |
| Jun 30, 2018 | 13,239.00 |
| Mar 31, 2018 | 262,769.00 |